Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors.
3,225,000 shares of common stock will be purchased at $1.20 per share.
The gross proceeds from the offering are expected to be approximately $3.9 million.
Direct Stock Offering
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Approximately $3.9 million expected before deducting fees.
Closing Date
Offering expected to close on August 15, 2025.
Placement Agent
Maxim Group LLC is acting as sole placement agent.
- The offering is being made through a registered direct offering.
- The company aims to raise funds for future operations and developments.
This direct stock offering marks a significant milestone for Scienture Holdings, Inc. as it seeks to enhance value for patients and stakeholders in the pharmaceutical sector.